{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-002273","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.867387+00:00","generated_at":"2026-05-27T06:17:41.118413+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Azenta recasts historical financials to reflect B Medical Systems as discontinued operations held for sale","bullets":["For FY2024 (12 months ended Sep 30, 2024), continuing ops revenue $573.2M, operating loss $50.6M.","Discontinued ops (B Medical) posted net loss of $140.5M for FY2024, classified as held for sale since Nov 12, 2024.","Recast data covers multiple prior periods to help investors isolate core Sample Management & Multiomics segments.","Sale of B Medical is intended to simplify portfolio and focus on core revenue growth and profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-002273","json":"https://secwatch.observer/filing/0001437749-25-002273.json","markdown":"https://secwatch.observer/filing/0001437749-25-002273.md","text":"https://secwatch.observer/filing/0001437749-25-002273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/0001437749-25-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/azta20250124_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:17:41.118413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}